PRTC logo

PRTC
Puretech Health

122
Mkt Cap
$419.9M
Volume
2,913.00
52W High
$19.92
52W Low
$14.50
PE Ratio
-3.78
PRTC Fundamentals
Price
$18.83
Prev Close
$17.25
Open
$18.77
50D MA
$16.83
Beta
0.43
Avg. Volume
4,499.72
EPS (Annual)
-$4.57
P/B
1.34
$143.92
Loading...
Loading...
News
all
press releases
PureTech Health H2 Earnings Call Highlights
PureTech Health (NASDAQ:PRTC) used its annual results call to outline a refined operating strategy centered on a leaner corporate structure, earlier formation of "founded entities," and an increased emphasis on returning capital to shareholders when significant inflows occur. Chief Executive Office...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
PureTech Health (NASDAQ:PRTC) Posts Quarterly Earnings Results, Beats Estimates By $0.59 EPS
PureTech Health (NASDAQ:PRTC - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($1.35) EPS for the quarter, topping analysts' consensus estimates of ($1.94...
MarketBeat·2d ago
News Placeholder
PureTech Announces Annual Results for Year Ended December 31, 2025
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (PureTech or the Company) today announces its results for the year ended December 31, 2025, as well as its cash balance as of the first quarter ended...
Business Wire·2d ago
News Placeholder
PureTech Announces Intention to Voluntarily Delist American Depositary Shares from Nasdaq and Concentrate Trading on the London Stock Exchange
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today...
Business Wire·2d ago
News Placeholder
PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, notes...
Business Wire·4d ago
News Placeholder
PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML)
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a hub-and-spoke biotherapeutics company dedicated to giving life to science and transforming innovation into value, today...
Business Wire·9d ago
News Placeholder
PureTech Health (PRTC) Expected to Announce Earnings on Wednesday
PureTech Health (NASDAQ:PRTC) will be releasing its H2 2025 earnings before the market opens on Wednesday, April 29. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-29-puretech-health-plc-stock...
MarketBeat·9d ago
News Placeholder
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC) Short Interest Up 30.8% in March
PureTech Health PLC Sponsored ADR (NASDAQ:PRTC - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totaling 14,823 shares, a...
MarketBeat·16d ago
News Placeholder
PureTech Health: Notice of Results
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company') plans to publish its Annual Report and Accounts and financial results for the year ended December 31, 2025, on Wednesday...
Business Wire·18d ago
News Placeholder
PureTech Health (LON:PRTC) Shares Cross Below Fifty Day Moving Average - Here's What Happened
PureTech Health (LON:PRTC) Shares Cross Below 50 Day Moving Average - Time to Sell...
MarketBeat·20d ago
<
1
2
...
>

Latest PRTC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.